Solid-Supported Sulfonylhydroxylamine as an Effective N-Aminating Agent of Anilines

Hiroshi Ohno; Hiroshi Tanaka; Takashi Takahashi

doi:10.1055/s-2005-865218

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2005(7): 1191-1194
DOI: 10.1055/s-2005-865218

LETTER

Solid-Supported Sulfonylhydroxylamine as an Effective N-Aminating Agent of Anilines

Hiroshi Ohno*^a, Hiroshi Tanaka^b, Takashi Takahashi*^b
^a Department of Medicinal Chemistry, Pharmaceutical Research Laboratory, Toray Industries, Inc., 1111 Tebiro, Kamakura, Kanagawa 248-8555, Japan
Fax: +81(467)324791; e-Mail: Hiroshi_Ono@nts.toray.co.jp;
^b Department of Applied Chemistry, Tokyo Institute of Technology, Meguro, Tokyo 152-8552, Japan

Further Information

Publication History

Received 16 November 2004
Publication Date:
20 April 2005 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

An effective method for the synthesis of aryl hydrazines by amination of anilines using the solid-supported phenylsulfonylhydroxylamine was described. Treatment of aniline with the solid-supported aminating agent, followed by removal of the resin, provided the corresponding hydrazine in 21% yield. The resulting hydrazines were directly adapted to the solid-phase synthesis of indoles, providing nine naltrindole derivatives varying the substituents on the aromatic rings.

Key words

electrophilic aminations - hydrazines - indoles - naltrindoles - solid-phase synthesis

References

For reviews on synthesis of heterocycles, see:
1a Krchnak V. Holladay MW. Chem. Rev. 2002, 102: 61

Crossref PubMed Google Scholar
1b Franzen RG. J. Comb. Chem. 2000, 2: 195

Crossref PubMed Google Scholar
1c Horton DA. Bourne GT. Smythe ML. Chem. Rev. 2003, 103: 893

Crossref PubMed Google Scholar
For recent studies on synthesis of aryl hydrazines and their derivatives, see:
2a Wang Z. Skerlj RT. Bridger GJ. Tetrahedron Lett. 1999, 40: 3543

Crossref Google Scholar
2b Wagaw S. Yang HB. Buchwald SL. J. Am. Chem. Soc. 1998, 120: 6621

Crossref Google Scholar
2c Hartwig JF. Angew. Chem. Int. Ed. 1998, 37: 2090

Crossref Google Scholar
2d Demers JP. Klaubert DH. Tetrahedron Lett. 1987, 28: 4933

Crossref Google Scholar
3 On the biological activity of indoles, see: Sunberg RJ. Indoles Academic Press; London: 1996. and references therein

Google Scholar
4 Haddad N. Baron J. Tetrahedron Lett. 2002, 43: 2171 ; and references therein

Crossref Google Scholar
5 Hunsberger IM. Shaw ER. Fugger J. Ketcham R. Lednicer D. J. Org. Chem. 1956, 21: 394

Crossref Google Scholar
6 Brown DW. Mahon MF. Ninan A. Sainsbury M. Shertzer HG. Tetrahedron 1993, 49: 8919

Crossref Google Scholar
7 For a review on sulfonylhydroxylamine, see: Tamura Y. Minamikawa J. Ikeda M. Synthesis 1977, 1

Article in Thieme Connect Google Scholar
For synthesis of sulfonylhydroxylamine, see:
8a Glover EE. Rowbottom KT. J. Chem. Soc., Perkin Trans. 1 1976, 367

Google Scholar
8b Batori S. Timari G. Koczka I. Hermecz I. Bioorg. Med. Chem. Lett. 1996, 6: 1507

Google Scholar
8c Greck C. Bischoff L. Girard A. Hajicek J. Genet JP. Bull. Soc. Chim. Fr. 1994, 131: 429

Google Scholar
9 Explosion in attempting to dry O-mesitylenesulfonyl-hydroxylamine has been reported, see: Scopes DIC. Kluge AF. Edwards JA. J. Org. Chem. 1977, 42: 376

Google Scholar
For solid-supported reagent, see:
10a Booth RJ. Hodges JC. Acc. Chem. Res. 1999, 32: 18

Crossref PubMed Google Scholar
10b Parlow JJ. Devraj RV. South MS. Curr. Opin. Chem. Biol. 1999, 3: 320

Crossref PubMed Google Scholar
10c Thompson LA. Curr. Opin. Chem. Biol. 2000, 4: 324

Crossref PubMed Google Scholar
10d Ley SV. Baxendale IR. Bream RN. Jackson PS. Leach AG. Longbottom DA. Nesi M. Scott JS. Storer RI. Taylor SJ. J. Chem. Soc., Perkin Trans. 1 2000, 3815

Crossref PubMed Google Scholar
10e Guillier F. Orain D. Bradley M. Chem. Rev. 2000, 100: 2091

Crossref PubMed Google Scholar
11a Portoghese PS. Sultana M. Nagase H. Takemori AE. J. Med. Chem. 1988, 31: 281

Crossref Google Scholar
11b Portoghese PS. Sultana M. Takemori AE. J. Med. Chem. 1990, 33: 1714

Crossref Google Scholar
15 Robinson R. The Fischer Indole Synthesis Wiley-Interscience; New York: 1982.

Google Scholar
16a Tanaka H. Ohno H. Kawamura K. Ohtake A. Nagase H. Takahashi T. Org. Lett. 2003, 5: 1159

Article in Thieme Connect Google Scholar
16b Ohno H. Tanaka H. Takahashi T. Synlett 2004, 508

Article in Thieme Connect Google Scholar

12

Procedure for the Preparation of 7.
To a mixture of PS-TsCl (Argonout, 1.97 mmol/g, 2.0 g, 3.9 mmol) and N-Boc-hydroxylamine (1.05 g, 7.9 mmol) in THF (32 mL) was added THF solution (4 mL) of Et₃N (1.1 mL, 7.9 mmol) slowly at 0 °C. The mixture was shaken for 1.5 h at r.t. After filtration of the mixture, the resulting resin was washed with THF, H₂O, and THF, and dried in vacuo to give resin-supported N-Boc sulfonyl hydroxylamine 7 (2.6 g). IR (resin): 1475, 1396, 1173 cm^-1. Anal. Found: C, 68.78; H, 7.40; N, 2.22; Cl, 0.02; S, 5.52%.

13

The ratio was estimated by ¹H NMR measurement of the crude mixture.

14

Typical Experimental Procedure.
To resin-supported N-Boc sulfonyl hydroxylamine (7, 100 mg), TFA (1 mL, pre-cooled at 0 °C) was added at r.t., and the mixture was shaken for 1 min at r.t. After filtration of the mixture, the resulting resin was washed with H₂O, THF, and CH₂Cl₂ (pre-cooled at 0 °C) to give the polystyrene-supported sulfonyl hydroxylamine 1B. The resulting resin was used for next amination without drying. To the resulting resin 1B was added aniline (27 µL, 0.29 mmol) in CH₂Cl₂ (0.5 mL, pre-cooled at 0 °C), and the mixture was shaken for 10 min at r.t. After filtration of the mixture followed by washing with CH₂Cl₂, the resulting resin were treated with CH₂Cl₂-HCl (10 M) in MeOH (1:1), filtered, and then washed with CH₂Cl₂-HCl (10 M) in MeOH (1:1). The combined filtrates were evaporated, and dried in vacuo to give of crude phenylhydrazine HCl (17.1 mg). Further purification was achieved by silica gel column chromatography followed by adding 10 M HCl in MeOH to give phenylhydrazine HCl (4.0 mg, 28 µmol).

17

The lower yield than previously reported [16a] was due to the different ways of estimation of the yield. The yield was determined by measurement of mass weight of cleavage product in the former paper, on the other hand in this paper the yield is isolated yield.

18

Spectra of 8d: ¹H NMR (400 MHz, CD₃OD): δ = 0.13-0.23 (2 H, m), 0.52-0.61 (2 H, m), 0.93 (1 H, m), 1.30 (3 H, t, J = 7.6 Hz), 1.72 (1 H, d, J = 12.2 Hz), 2.28-2.50 (4 H, m), 2.56 (1 H, d, J = 15.9 Hz), 2.73 (1 H, d, J = 15.9 Hz), 2.73-2.90 (4 H, m), 3.17 (1 H, d, J = 18.6 Hz), 3.40 (1 H, d, J = 6.3 Hz), 5.59 (1 H, s), 6.53 (1 H, d, J = 8.1 Hz), 6.56 (1 H, d, J = 8.1 Hz), 7.00 (1 H, d, J = 1.7 Hz), 7.34 (1 H, d, J = 1.7 Hz). ¹³C NMR (150.8 MHz, CD₃OD): δ = 4.2, 4.8, 10.3, 14.6, 24.1, 25.1, 29.8, 32.8, 45.0, 60.4, 63.4, 74.4, 85.7, 111.1, 113.0, 118.2, 119.6, 119.7, 124.4, 126.0, 129.3, 130.2, 131.8, 131.9, 135.8, 140.8, 144.5. MS (ESI): 521 [M + H]⁺.
Spectra of 8e: ¹H NMR (400 MHz, CD₃OD): δ = 0.13-0.22 (2 H, m), 0.51-0.60 (2 H, m), 0.93 (1 H, m), 1.73 (1 H, d, J = 12.5 Hz), 2.28-2.47 (4 H, m), 2.49 (3 H, s), 2.57 (1 H, d, J = 15.9 Hz), 2.68-2.85 (2 H, m), 2.76 (1 H, d, J = 15.9 Hz), 3.17 (1 H, d, J = 18.6 Hz), 3.40 (1 H, d, J = 6.3 Hz), 5.59 (1 H, s), 6.52 (1 H, d, J = 8.1 Hz), 6.55 (1 H, d, J = 8.1 Hz), 6.90 (1 H, d, J = 8.4 Hz), 7.16 (1 H, d, J = 8.4 Hz). ¹³C NMR (150.8 MHz, CD₃OD): δ = 4.2, 4.8, 10.3, 14.1, 24.1, 29.8, 32.7, 45.0, 60.4, 63.5, 74.4, 85.8, 111.8, 117.8, 118.2, 119.3, 119.6, 120.9, 125.9, 126.2, 128.4, 131.5, 131.9, 138.5, 140.8, 144.5. MS (ESI): 463 [M + H]⁺.
Spectra of 8f: ¹H NMR (400 MHz, CD₃OD): δ = 0.15-0.24 (2 H, m), 0.52-0.62 (2 H, m), 0.95 (1 H, m), 1.26-1.42 (18 H, m), 1.74 (1 H, m), 2.35-2.49 (4 H, m), 2.71-2.81 (3 H, m), 3.18-3.26 (2 H, m), 3.36 (1 H, d, J = 6.3 Hz), 5.61 (1 H, s), 6.53 (1 H, d, J = 8.2 Hz), 6.56 (1 H, d, J = 8.2 Hz), 7.05 (1 H, d, J = 1.7 Hz), 7.20 (1 H, d, J = 1.7 Hz). ¹³C NMR (150.8 MHz, CD₃OD): δ = 4.3, 4.7, 10.3, 24.2, 31.9, 32.2, 33.0, 35.6, 36.3, 36.5, 44.9, 48.0, 60.5, 63.9, 75.0, 86.6, 107.0, 108.9, 115.2, 118.2, 119.5, 122.6, 125.9, 130.9, 132.1, 140.1, 140.8, 144.3, 144.8, 145.1. MS (ESI): 527 [M + H]⁺.
Spectra of 8g: ¹H NMR (400 MHz, CD₃OD): δ = 0.15-0.24 (2 H, m), 0.52-0.61 (2 H, m), 0.94 (1 H, m), 1.73 (1 H, m), 1.81-1.91 (4 H, m), 2.31-2.49 (4 H, m), 2.59 (1 H, d, J = 15.9 Hz), 2.75-2.87 (7 H, m), 3.17 (1 H, d, J = 18.6 Hz), 3.41 (1 H, d, J = 5.9 Hz), 5.60 (1 H, s), 6.52 (1 H, d, J = 8.2 Hz), 6.54 (1 H, d, J = 8.2 Hz), 6.67 (1 H, d, J = 8.1 Hz), 7.10 (1 H, d, J = 8.1 Hz). ¹³C NMR (150.8 MHz, CD₃OD): δ = 4.2, 4.8, 10.2, 24.2, 24.2, 24.9, 25.4, 30.0, 30.6, 32.7, 45.0, 49.9, 60.4, 63.5, 74.4, 86.3, 116.7, 118.1, 119.4, 120.4, 121.5, 125.3, 125.9, 129.5, 131.3, 132.1, 137.7, 140.8, 144.5, 150.4. MS (ESI): 469 [M + H]⁺.
Spectra of 8h: ¹H NMR (400 MHz, CD₃OD): δ = 0.12-0.22 (2 H, m), 0.49-0.60 (2 H, m), 0.92 (1 H, m), 1.75 (1 H, d, J = 12.7 Hz), 2.27-2.46 (4 H, m), 2.66 (1 H, d, J = 15.6 Hz), 2.71-2.76 (1 H, m), 2.83 (1 H, d, J = 18.6 Hz), 2.84 (1 H, d, J = 15.9 Hz), 3.17 (1 H, d, J = 18.6 Hz), 3.42 (1 H, d, J = 6.3 Hz), 5.68 (1 H, s), 6.54 (1 H, d, J = 8.2 Hz), 6.57 (1 H, d, J = 8.2 Hz), 7.45-7.49 (1 H, m), 7.51-7.55 (1 H, m), 7.58 (1 H, s), 8.19-8.23 (2 H, m). ¹³C NMR (150.8 MHz, CD₃OD): δ = 4.2, 4.7, 10.2, 24.1, 29.7, 32.7, 44.8, 60.3, 63.3, 74.4, 85.7, 112.6, 118.0, 119.5, 119.7, 121.7, 122.8, 123.5, 123.9, 125.3, 125.8, 125.9, 126.8, 128.2, 129.9, 131.7, 132.3, 140.6, 144.4. MS (ESI): 499 [M + H]⁺.
Spectra of 8i: ¹H NMR (400 MHz, CD₃OD): δ = 0.12-0.24 (2 H, m), 0.51-0.62 (2 H, m), 0.87-0.97 (1 H, m), 1.73-1.76 (1 H, m), 2.28-2.50 (4 H, m), 2.63 (1 H, d, J = 14.6 Hz), 2.72-2.88 (2 H, m), 2.81 (1 H, d, J = 15.6 Hz), 3.18 (1 H, d, J = 18.6 Hz), 3.42 (1 H, d, J = 6.6 Hz), 3.81 (1 H, d, J = 22.0 Hz), 3.90 (1 H, d, J = 21.7 Hz), 5.63 (1 H, s), 6.54 (1 H, d, J = 8.1 Hz), 6.56 (1 H, d, J = 8.1 Hz), 7.15-7.19 (1 H, m), 7.26-7.30 (1 H, m), 7.31 (1 H, d, J = 8.1 Hz), 7.41 (1 H, d, J = 8.3 Hz), 7.46 (1 H, d, J = 7.3 Hz), 7.68 (1 H, d, J = 7.6 Hz). ¹³C NMR (150.8 MHz, CD₃OD): δ = 4.2, 4.8, 10.3, 24.2, 30.1, 32.7, 35.2, 45.0, 60.4, 63.5, 74.4, 86.1, 112.2, 112.4, 118.2, 118.5, 119.6, 119.8, 125.6, 126.0, 126.1, 126.5, 127.4, 127.6, 131.0, 132.1, 135.5, 137.8, 140.9, 143.5, 144.4, 144.6. MS (ESI): 503 [M + H]⁺.